Skip to main content

Neurogene Inc.

NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404644

In the last 90 days, Neurogene Inc. insiders filed 0 open-market purchases and 2 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Neurogene Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
−5 vs. Q3 2022
Shares held
17.0M
−1.50M (−8.1%) vs. Q3 2022
Total value
$8.66M
−$3.19M (−26.9%) vs. Q3 2022
New holders
7
7 more added
Sold out
12
16 more reduced

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NGNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 46 institutions
Q1 2021: 82 institutionsQ2 2021: 82 institutionsQ3 2021: 85 institutionsQ4 2021: 80 institutionsQ1 2022: 81 institutionsQ2 2022: 64 institutionsQ3 2022: 52 institutionsQ4 2022: 46 institutionsQ1 2023: 39 institutionsQ2 2023: 36 institutionsQ3 2023: 31 institutionsQ4 2023: 35 institutionsQ1 2024: 60 institutionsQ2 2024: 66 institutionsQ3 2024: 86 institutionsQ4 2024: 89 institutionsQ1 2025: 86 institutionsQ2 2025: 83 institutionsQ3 2025: 88 institutionsQ4 2025: 93 institutionsQ1 2026: 96 institutionsQ2 2026: 111 institutions
Value heldQ4 2022: $8.66M
Q1 2021: $341.9MQ2 2021: $248.8MQ3 2021: $187.1MQ4 2021: $118.8MQ1 2022: $46.3MQ2 2022: $21.4MQ3 2022: $12.0MQ4 2022: $8.66MQ1 2023: $10.5MQ2 2023: $14.3MQ3 2023: $14.4MQ4 2023: $179.0MQ1 2024: $617.3MQ2 2024: $482.7MQ3 2024: $581.1MQ4 2024: $367.8MQ1 2025: $192.8MQ2 2025: $230.1MQ3 2025: $265.2MQ4 2025: $340.4MQ1 2026: $342.0MQ2 2026: $544.4M
Institutions holding NGNE and their total value by quarter
QuarterHoldersValue
Q2 2026111$544.4M
Q1 202696$342.0M
Q4 202593$340.4M
Q3 202588$265.2M
Q2 202583$230.1M
Q1 202586$192.8M
Q4 202489$367.8M
Q3 202486$581.1M
Q2 202466$482.7M
Q1 202460$617.3M
Q4 202335$179.0M
Q3 202331$14.4M
Q2 202336$14.3M
Q1 202339$10.5M
Q4 202246$8.66M
Q3 202252$12.0M
Q2 202264$21.4M
Q1 202281$46.3M
Q4 202180$118.8M
Q3 202185$187.1M
Q2 202182$248.8M
Q1 202182$341.9M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Neurogene Inc.; share changes are against Q3 2022.

Institutions holding NGNE in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Baker Bros. Advisors LP3,821,740$1.95M0.01%00.0%Unchanged
Lynx1 Capital Management LP2,291,133$1.17M1.01%+2,291,133New
Redmile Group, LLC1,850,566$941.9K0.04%−1,586,369−46.2%Reduced
Bank of America Corp1,623,893$826.6K0.00%+1,448,031+823.4%Added
Millennium Management LLC1,587,267$808.0K0.00%−108,116−6.4%Reduced
Renaissance Technologies LLC1,193,447$607.0K0.00%−248,620−17.2%Reduced
Vanguard Group Inc1,016,296$517.3K0.00%−9,590−0.9%Reduced
BlackRock Inc.613,942$312.5K0.00%−275,356−31.0%Reduced
Morgan Stanley562,423$286.3K0.00%−30,038−5.1%Reduced
Barclays PLC452,250$230.2K0.00%00.0%Unchanged
Geode Capital Management, LLC301,057$153.0K0.00%−726−0.2%Reduced
Two Sigma Investments, LP299,036$152.2K0.00%−44,100−12.9%Reduced
Two Sigma Advisers, LP250,300$127.4K0.00%−143,700−36.5%Reduced
Point72 Asset Management, L.P.136,675$69.6K0.00%−1,927,547−93.4%Reduced
State Street Corp122,556$62.4K0.00%00.0%Unchanged
Kynam Capital Management, LP120,764$61.5K0.01%+396+0.3%Added
Privium Fund Management (UK) Ltd117,200$59.7K0.05%00.0%Unchanged
Bridgeway Capital Management, LLC75,000$38.2K0.00%−8,800−10.5%Reduced
JPMorgan Chase & Co72,967$37.0K0.00%+16,035+28.2%Added
Northern Trust Corp69,765$35.5K0.00%00.0%Unchanged
Jane Street Group, LLC60,667$30.9K0.00%+60,667New
HighTower Advisors, LLC48,409$25.0K0.00%+48,409New
Simon Quick Advisors, LLC46,856$23.9K0.00%00.0%Unchanged
Sio Capital Management, LLC38,312$19.5K0.01%00.0%Unchanged
Susquehanna International Group, LLP26,556$13.5K0.00%+26,556New
Ergoteles LLC24,037$12.2K0.00%−127,283−84.1%Reduced
UBS Group AG21,789$11.1K0.00%+7,289+50.3%Added
US Bancorp21,000$10.7K0.00%00.0%Unchanged
Acadian Asset Management LLC21,188$10.0K0.00%00.0%Unchanged
Janney Montgomery Scott LLC20,000$10.0K0.00%00.0%Unchanged
Endurance Wealth Management, Inc.20,000$10.0K0.00%+10,000+100.0%Added
Nomura Holdings Inc16,246$8.00K0.00%00.0%Unchanged
Bank of New York Mellon Corp14,372$7.32K0.00%00.0%Unchanged
Kestra Advisory Services, LLC13,341$6.79K0.00%+13,341New
Bank of Montreal10,467$5.43K0.00%+10,467New
Dimensional Fund Advisors LP10,365$5.00K0.00%00.0%Unchanged
Tri Locum Partners LP10,248$5.00K0.00%+10,248New
Wells Fargo & Company8,229$4.19K0.00%+6+0.1%Added
Federated Hermes, Inc.4,507$2.29K0.00%+207+4.8%Added
Tower Research Capital LLC (TRC)3,762$2.00K0.00%−6,212−62.3%Reduced
Group One Trading, L.P.2,001$1.02K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,500$1.00K0.00%00.0%Unchanged
Truvestments Capital LLC925$4710.00%00.0%Unchanged
Citigroup Inc270$1370.00%−518−65.7%Reduced
Cubist Systematic Strategies, LLC9$50.00%−6,104−99.9%Reduced
Royal Bank of Canada206$00.00%−319−60.8%Reduced
Opaleye Management Inc.0$00.00%−575,000−100.0%Sold out
Royce & Associates LP0$00.00%−145,397−100.0%Sold out
Adviser Investments LLC0$00.00%−53,811−100.0%Sold out
Highland Private Wealth Management0$00.00%−46,999−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−24,386−100.0%Sold out
Clarius Group, LLC0$00.00%−23,514−100.0%Sold out
Price T Rowe Associates Inc0$00.00%−20,300−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−15,741−100.0%Sold out
LMR Partners LLP0$00.00%−12,559−100.0%Sold out
Credit Suisse AG0$00.00%−20−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−79−100.0%Sold out
China Universal Asset Management Co., Ltd.0$00.00%−399−100.0%Sold out
ACT Capital Management, LLC––––Not filed